153 related articles for article (PubMed ID: 19527769)
1. Arsenite medicinal use, metabolism, pharmacokinetics and monitoring in human hair.
Nicolis I; Curis E; Deschamps P; Bénazeth S
Biochimie; 2009 Oct; 91(10):1260-7. PubMed ID: 19527769
[TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
Quezada G; Kopp L; Estey E; Wells RJ
Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
[TBL] [Abstract][Full Text] [Related]
3. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
4. Microprobe XRF mapping and XAS investigations of the intracellular metabolism of arsenic for understanding arsenic-induced toxicity.
Munro KL; Mariana A; Klavins AI; Foster AJ; Lai B; Vogt S; Cai Z; Harris HH; Dillon CT
Chem Res Toxicol; 2008 Sep; 21(9):1760-9. PubMed ID: 18597498
[TBL] [Abstract][Full Text] [Related]
5. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
Korístek Z; Mayer J
Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.
Fujisawa S; Ohno R; Shigeno K; Sahara N; Nakamura S; Naito K; Kobayashi M; Shinjo K; Takeshita A; Suzuki Y; Hashimoto H; Kinoshita K; Shimoya M; Kaise T; Ohnishi K
Cancer Chemother Pharmacol; 2007 Mar; 59(4):485-93. PubMed ID: 16937107
[TBL] [Abstract][Full Text] [Related]
7. Characterizing arsenic in preserved hair for assessing exposure potential and discriminating poisoning.
Kempson IM; Henry D; Francis J
J Synchrotron Radiat; 2009 May; 16(Pt 3):422-7. PubMed ID: 19395809
[TBL] [Abstract][Full Text] [Related]
8. What is the role of arsenic in newly diagnosed APL?
Tallman MS
Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
[TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukemia: recent advances in diagnosis and management.
Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
11. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.
Knipp S; Gattermann N; Schapira M; Käferstein H; Germing U
Leuk Res; 2007 Nov; 31(11):1585-7. PubMed ID: 17416415
[TBL] [Abstract][Full Text] [Related]
12. [Effect of additional chromosome abnormalities on the outcome of newly diagnosed acute promyelocytic leukemia treated with red arsenic sulfide and all trans-retinoic acid plus anthracyclin based protocol].
Lu J; Jiang H; Jiang Q; Bao L; Lu XJ; Zhang Y; Lin W; Liu YR; Huang XJ; Jiang B
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2254-7. PubMed ID: 19087672
[TBL] [Abstract][Full Text] [Related]
13. The expanding role of arsenic in acute promyelocytic leukemia.
Tallman MS
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience.
Zhang L; Zhao H; Zhu X; Chen Y; Zou Y; Chen X
Pediatr Blood Cancer; 2008 Aug; 51(2):210-5. PubMed ID: 18428427
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide mutational spectrum analysis in the mouse lymphoma assay.
Soriano C; Creus A; Marcos R
Mutat Res; 2008 Nov; 646(1-2):1-7. PubMed ID: 18822301
[TBL] [Abstract][Full Text] [Related]
16. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
17. XAS applied to pharmaceuticals: drug administration and bioavailability.
Nicolis I; Deschamps P; Curis E; Corriol O; Acar V; Zerrouk N; Chaumeil JC; Guyon F; Bénazeth S
J Synchrotron Radiat; 2001 Mar; 8(Pt 2):984-6. PubMed ID: 11513002
[TBL] [Abstract][Full Text] [Related]
18. Arsenic in induced hair of the rat and its relation to the content in various organs during chronic exposure.
Kollmer WE
J Trace Elem Electrolytes Health Dis; 1992 Mar; 6(1):11-4. PubMed ID: 1638178
[TBL] [Abstract][Full Text] [Related]
19. The dose response of arsenic in induced hair of the rat and its relation to the content in various organs following acute exposure.
Kollmer WE
J Trace Elem Electrolytes Health Dis; 1990 Jun; 4(2):79-85. PubMed ID: 2136229
[TBL] [Abstract][Full Text] [Related]
20. [Relapse in acute promyelocytic leukemia and the role of hematopoietic stem cell transplantation in the treatment of APL].
Zák P; Korístek Z
Vnitr Lek; 2008; 54(7-8):751-6. PubMed ID: 18780574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
